Surprising FDA audit report of Celltex a blow to dubious stem cell clinics
As I first reported, the FDA conducted a two-week audit of Texas adult stem cell firm, Celltex, sometime in April. Today I received a copy of the so-called “483 report” of that audit. It is basically a summary of problematic issues that the FDA says need to addressed. The FDA report is cause for some […]
Surprising FDA audit report of Celltex a blow to dubious stem cell clinics Read More »